GDF-5 and BMP-2 regulate bone cell differentiation by gene expression of MSX1, MSX2, Dlx5, and Runx2 and influence OCN gene expression in vitro

International Journal of Periodontics and Restorative Dentistry

Volumn 32, Issue 3, 2012, Pages 285-293

  Koch, Felix Peter ^a   Weinbach, Christoph ^a   Hustert, Elisabeth ^b   Al Nawas, Bilal ^a   Wagner, Wilfried ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b SCIL Diagnostics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DLX5 PROTEIN, HUMAN; GROWTH DIFFERENTIATION FACTOR 5; HOMEODOMAIN PROTEIN; MESSENGER RNA; MSX1 PROTEIN, HUMAN; OSTEOCALCIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; RUNX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HUMAN; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

BONE MORPHOGENETIC PROTEIN 2; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GROWTH DIFFERENTIATION FACTOR 5; HOMEODOMAIN PROTEINS; HUMANS; MSX1 TRANSCRIPTION FACTOR; OSTEOBLASTS; OSTEOCALCIN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864872484     PISSN: 01987569     EISSN: 19453388     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Urist MR. Bone: Formation by autoinduction. Science 1965 150: 893-899.
2. Lee MH, Kim YJ, Yoon WJ, et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 2005; 280: 35579-35587.
3. Wang EA, Rosen V, D’Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990; 87: 2220-2224.
4. Dohzono S, Imai Y, Nakamura H, Wakitani S, Takaoka K. Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous beta-TCP granules: A pilot study. Clin Orthop Relat Res 2009; 467: 3206-3212.
5. Boyne PJ, Marx RE, Nevins M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997; 17: 11-25.
6. Rosen V, Wozney JM, Bone morphogenetic proteins. In: Bilezikian JP, Raisz LG, Rodan GA (eds). Principles of Bone Biology, ed 2. San Diego: Academic Press, 2002.
7. Chen X, Zankl A, Niroomand F, et al. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J Mol Cell Cardiol 2006; 41: 26-33.
8. Hurley FM, Costello DJ, Sullivan AM. Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson’s disease. Exp Neurol 2004; 185: 281-289.
9. O’Keeffe G, Costello D, Hanke M, Sullivan A. 28 Growth differentiation factor-5 (GDF-5) expression in the rat brain: Developmental regulator, potential treatment? J Anat 2002;201: 425.
10. Jenner JM, van Eijk F, Saris DB, Willems WJ, Dhert WJ, Creemers LB. Effect of transforming growth factor-beta and growth differentiation factor-5 on proliferation and matrix production by human bone marrow stromal cells cultured on braided poly lactic-co-glycolic acid scaffolds for ligament tissue engineering. Tissue Eng 2007; 13: 1573-1582.
11. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 1994; 368: 639-643.
12. Grünenberg H, Lee AJ. The anatomy and development of brachypodism in the mouse. J Embryol Exp Morph 1973; 30: 119-141.
13. Landauer W. Brachypodism, a recessive mutation of house-mice. J Hered 1952; 43: 293-298.
14. Spiro RC, Liu LS, Heidaran MA, et al. Inductive activity of recombinant human growth and differentiation factor-5. Biochem Soc Trans 2000; 28: 362-368.
15. Jezewski PA, Vieira AR, Nishimura C, et al. Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet 2003; 40: 399-407.
16. Suzuki Y, Jezewski PA, Machida J, et al. In a Vietnamese population, MSX1 variants contribute to cleft lip and palate. Genet Med 2004; 6: 117-125.
17. Mostowska A, Biedziak B, Trzeciak WH. A novel c.581C>T transition localized in a highly conserved homeobox sequence of MSX1: Is it responsible for oligodontia? J Appl Genet 2006;47: 159-164.
18. Mikic B. Multiple effects of GDF-5 deficiency on skeletal tissues: Implications for therapeutic bioengineering. Ann Biomed Eng 2004; 32: 466-476.
19. Poehling S, Pippig SD, Hellerbrand K, Siedler M, Schütz A, Dony C. Superior effect of MD05, beta-tricalcium phosphate coated with recombinant human growth/ differentiation factor-5, compared to conventional bone substitutes in the rat calvarial defect model. J Periodontol 2006; 77: 1582-1590.
20. Schwarz F, Rothamel D, Herten M, Ferrari D, Sager M, Becker J. Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: An immunohistochemical study in dogs. Clin Oral Implants Res 2008; 19: 642-652.
21. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, New Jersey: Humana Press, 2000: 365-386.
22. Newberry EP, Latifi T, Towler DA. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 1998; 37: 16360-16368.
23. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 2003; 278: 45969-45977.
24. Mostowska A, Kobielak A, Trzeciak WH. Molecular basis of non-syndromic tooth agenesis: Mutations of MSX1 and PAX9 reflect their role in patterning human dentition. Eur J Oral Sci 2003; 111: 365-370.
25. Jabs EW, Müller U, Li X, et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993; 75: 443-450.
26. Polinkovsky A, Robin NH, Thomas JT, et al. Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 1997; 17: 18-19.
27. Thomas JT, Kilpatrick MW, Lin K, et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 1997; 17: 58-64.
28. Weinstein M, Yang X, Deng C. Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev 2000; 11: 49-58.
29. Dodig M, Tadic T, Kronenberg MS, et al. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev Biol 1999; 209: 298-307.
30. Ryoo HM, Lee MH, Kim YJ. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 2006; 366: 51-57.
31. Ryoo HM, Hoffmann HM, Beumer T, et al. Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression. Mol Endocrinol 1997; 11: 1681-1694.
32. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003; 309: 689-694.
33. Nishitoh H, Ichijo H, Kimura M, et al. Identification of type I and type II serine/ threonine kinase receptors for growth/ differentiation factor-5. J Biol Chem 1996; 271: 21345-21352.
34. Lee KS, Kim HJ, Li QL, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblastspecific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000; 20: 8783-8792.
35. Hassan MQ, Javed A, Morasso MI, et al. Dlx3 transcriptional regulation of osteoblast differentiation: Temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 2004; 24: 9248-9261.
36. Yoshimoto T, Yamamoto M, Kadomatsu H, Sakoda K, Yonamine Y, Izumi Y. Recombinant human growth/differentiation factor-5 (rhGDF-5) induced bone formation in murine calvariae. J Periodontal Res 2006; 41: 140-147.